USA – Pfizer has announced the opening of a US$68.5 million gene therapy manufacturing facility in Durham, North Carolina, as part of a multi-yearUS$800 million plan to outfit its next-generation…
Read MoreYear: 2021
WHO appoints Dr. Ayoade Alakija as Covid-19 special envoy
SWITZERLAND – The World Health Organization has appointed a Nigerian, Dr. Ayoade Alakija, as the global health agency’s Special Envoy for the Access to COVID-19 Tools Accelerator (ACT-A). Dr. Tedros…
Read MoreQIC, Sunsuper buy New Zealand’s hospital platform
AUSTRALIA – Australian-based asset manager, Queensland Investment Corporation (QIC) and Sunsuper have agreed to buy Evolution Healthcare, New Zealand’s second-largest hospital operator. QIC made the investment on behalf of the…
Read MoreInnovaccer valued at US$3.2 billion after nabbing US$150 million funding
USA – Innovaccer Inc. a Silicon Valley-based healthcare data platform company, has announced US$150 million Series E round at US$3.2 billion valuation led by Mubadala Capital. Other existing investors included…
Read MoreSheba startups scoop over US$110 million to develop new healthcare technology
ISRAEL – Sheba Medical Center, Israel’s largest hospital, has announced that six companies from its ARC Innovation Center raised more than US$110 million in 2021. All companies are founded on…
Read MoreVakrangee ties up with PharmEasy to provide healthcare services across its platform
INDIA – Vakrangee Digital Ventures Limited, a wholly owned subsidiary of Vakrangee Ltd has partnered with PharmEasy to provide online medicines and healthcare services to India’s unserved and underserved populations.…
Read MoreUSFDA approves Sun Pharma’s generic Amphotericin B Liposome for injection
INDIA – Sun Pharmaceuticals Industries announced that one of its wholly-owned subsidiaries received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA)…
Read MoreCipla acquires one-third stake in Clean Max Auriga Power
INDIA – Cipla announced the acquisition of up to a 33% partnership interest in Clean Max Auriga Power in a deal that will see the latter become an associate of…
Read MoreBristol Myers Squibb’s Orencia becomes first drug approved for preventing graft-versus-host disease
USA – The US Food and Drug Administration (FDA) has given Orencia approval as a preventative therapy for acute graft-versus-host disease (GVHD) in combination with certain immunosuppressants. Orencia is the…
Read MoreMedtech startup Neurovalens secures funding for mental health treatment
IRELAND – Neurovalens, an Irish-based health-technology company, has received new funding to conduct clinical trials of its technology for the treatment of anxiety and post-traumatic stress disorder (PTSD). The company,…
Read More